SLU-PP-332
ResearchAn ERR agonist (exercise mimetic) that activates the same pathways as endurance exercise without physical activity. Researched for metabolic improvement and heart failure.
Metabolic HealthCardiovascularEnergy & Performance
Half Life
Unknown
Time to Results
Weeks
Administration
Oral
🐾 Griffin's Research Scorecard
Research Strength
Human Data
Animal Data
Long-Term Data
Beginner Friendly
Storage Difficulty
Injection FrequencyDaily (oral)
Cost$$$
🐾 Griffin Says...
The 'exercise in a pill' concept. SLU-PP-332 activates the ERR nuclear receptors that are normally triggered by exercise. Animal research showed mice running 70% further than controls without training. Still very early stage for humans but conceptually fascinating.
Benefits
- Exercise-like metabolic effects without exercise
- Improved endurance capacity in animals
- Cardiovascular protection
- Fat metabolism improvement
Best For
- Metabolic research
- Exercise mimetic research
- Heart failure research
Body Systems
MetabolicCardiovascularMusculoskeletal
Mechanisms of Action
- ERRα/β/γ agonist
- Activates mitochondrial biogenesis
- Mimics exercise adaptation pathways
- PPAR-like effects
Side Effects
| Effect | Frequency | Severity |
|---|---|---|
| Unknown long-term profile | Unknown | Unknown |
Contraindications
Extremely limited human data
Peptides discussed here are for research purposes only. Nothing on this page is medical advice. Always consult a qualified professional before making health decisions.
Ready to calculate your dose? Use Griffin's Peptide Calculator 🐾
Open Calculator